InsiderTrades.com logo
The Secret Weapon You Need for This Bull Market
From Crypto Swap Profits   |   Ad
The 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But here’s the thing: most people won’t be able to keep up with the pace of the market. But there’s a way to trade this market with precision – without the stress, without the guesswork.
Register for the FREE Workshop Now & get $10 in Bitcoin

PHGE Insider Trading

Insider Ownership Percentage: 3.01%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $9,249.20

BiomX Insider Trading History Chart

This chart shows the insider buying and selling history at BiomX by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

BiomX Share Price & Price History

Current Price: $0.87
Price Change: ▼ Price Decrease of -0.02 (-2.24%)
As of 10/25/2024 01:00 AM ET

This chart shows the closing price history over time for PHGE up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Next opportunity for crypto millions
From Crypto 101 Media   |   Ad
According to Steven Lubka, head of a private equity firm with over $250M in assets under management, "Bitcoin is poised to reach six-figures, no matter who wins the U.S. presidential election…" And as Bitcoin rallies, we could see other smaller coins rise to heights never seen before. Coins that you may not have even heard of before could shoot up 10x, 20x, maybe even 150x in the coming months…
Just click here to request my "Bull Run Millionaire Blueprint" now.

BiomX Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/15/2024Israel Biofund Gp Limi OrbimedMajor ShareholderSell2,434$3.80$9,249.201,377,365View SEC Filing Icon  
5/22/2023Assaf OronInsiderBuy319$2.70$861.301,091View SEC Filing Icon  
2/27/2023Israel Biofund Gp Limi OrbimedMajor ShareholderBuy34,800$2.40$83,520.00316,148View SEC Filing Icon  
11/4/2022Chidozie UgwumbaMajor ShareholderSell150$3.80$570.00299,702View SEC Filing Icon  
11/2/2022Chidozie UgwumbaMajor ShareholderSell241$3.60$867.60300,052View SEC Filing Icon  
10/31/2022Chidozie UgwumbaMajor ShareholderSell330$3.70$1,221.00300,424View SEC Filing Icon  
10/28/2022Chidozie UgwumbaMajor ShareholderSell152$3.60$547.20300,754View SEC Filing Icon  
10/26/2022Chidozie UgwumbaMajor ShareholderSell1,250$3.50$4,375.00301,057View SEC Filing Icon  
10/24/2022Chidozie UgwumbaMajor ShareholderSell590$3.50$2,065.00302,614View SEC Filing Icon  
10/21/2022Chidozie UgwumbaMajor ShareholderSell540$3.70$1,998.00303,204View SEC Filing Icon  
10/19/2022Chidozie UgwumbaMajor ShareholderSell450$3.70$1,665.00304,408View SEC Filing Icon  
10/17/2022Chidozie UgwumbaMajor ShareholderSell809$3.40$2,750.60306,388View SEC Filing Icon  
10/14/2022Chidozie UgwumbaMajor ShareholderSell342$3.30$1,128.60307,198View SEC Filing Icon  
10/12/2022Chidozie UgwumbaMajor ShareholderSell970$3.30$3,201.00308,671View SEC Filing Icon  
10/10/2022Chidozie UgwumbaMajor ShareholderSell1,004$3.30$3,313.20310,240View SEC Filing Icon  
10/7/2022Chidozie UgwumbaMajor ShareholderSell2,470$3.60$8,892.00311,244View SEC Filing Icon  
10/5/2022Chidozie UgwumbaMajor ShareholderSell4,678$4.30$20,115.40316,225View SEC Filing Icon  
10/3/2022Chidozie UgwumbaMajor ShareholderSell1,502$3.30$4,956.60322,823View SEC Filing Icon  
9/30/2022Chidozie UgwumbaMajor ShareholderSell866$3.60$3,117.60324,325View SEC Filing Icon  
9/28/2022Chidozie UgwumbaMajor ShareholderSell1,564$3.30$5,161.20325,522View SEC Filing Icon  
9/26/2022Chidozie UgwumbaMajor ShareholderSell1,752$3.50$6,132.00327,573View SEC Filing Icon  
9/23/2022Chidozie UgwumbaMajor ShareholderSell530$3.70$1,961.00329,326View SEC Filing Icon  
9/21/2022Chidozie UgwumbaMajor ShareholderSell557$4.30$2,395.10331,595View SEC Filing Icon  
9/19/2022Chidozie UgwumbaMajor ShareholderSell1,387$4.80$6,657.60333,215View SEC Filing Icon  
9/16/2022Chidozie UgwumbaMajor ShareholderSell320$5.10$1,632.00334,602View SEC Filing Icon  
9/14/2022Chidozie UgwumbaMajor ShareholderSell230$5.20$1,196.00335,312View SEC Filing Icon  
9/12/2022Chidozie UgwumbaMajor ShareholderSell170$5.40$918.00335,762View SEC Filing Icon  
9/8/2022Chidozie UgwumbaMajor ShareholderSell459$5.20$2,386.80337,254View SEC Filing Icon  
9/6/2022Chidozie UgwumbaMajor ShareholderSell640$5.50$3,520.00338,598View SEC Filing Icon  
9/2/2022Chidozie UgwumbaMajor ShareholderSell200$5.50$1,100.00339,238View SEC Filing Icon  
8/31/2022Chidozie UgwumbaMajor ShareholderSell454$5.50$2,497.00340,268View SEC Filing Icon  
8/29/2022Chidozie UgwumbaMajor ShareholderSell1,153$5.70$6,572.10342,071View SEC Filing Icon  
8/26/2022Chidozie UgwumbaMajor ShareholderSell6,062$6.20$37,584.40343,224View SEC Filing Icon  
8/24/2022Chidozie UgwumbaMajor ShareholderSell866$6.50$5,629.00351,982View SEC Filing Icon  
8/22/2022Chidozie UgwumbaMajor ShareholderSell500$6.60$3,300.00353,438View SEC Filing Icon  
8/19/2022Chidozie UgwumbaMajor ShareholderSell1,460$6.40$9,344.00353,938View SEC Filing Icon  
8/17/2022Chidozie UgwumbaMajor ShareholderSell2,133$6.90$14,717.70356,174View SEC Filing Icon  
8/15/2022Chidozie UgwumbaMajor ShareholderSell720$7.50$5,400.00359,164View SEC Filing Icon  
8/12/2022Chidozie UgwumbaMajor ShareholderSell1,140$7.30$8,322.00359,884View SEC Filing Icon  
8/10/2022Chidozie UgwumbaMajor ShareholderSell1,776$7.40$13,142.40362,007View SEC Filing Icon  
See Full Table
Watch this before it gets removed
From Porter & Company   |   Ad
If you missed it, my emergency election broadcast is now available - but will be removed soon
Click here to watch it now.

SEC Filings (Institutional Ownership Changes) for BiomX (NYSEMKT:PHGE)

40.57% of BiomX stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at PHGE by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

BiomX Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/17/2024Ikarian Capital LLC10,817,327$4.87M0.5%N/A19.590%Search for SEC Filing on Google Icon
5/10/2024Johnson & Johnson1,923,201$0.87M0.0%-9.9%3.483%Search for SEC Filing on Google Icon
11/3/2022Royce & Associates LP158,655$54K0.0%-51.7%0.529%Search for SEC Filing on Google Icon
5/5/2022Royce & Associates LP320,655$0.62M0.0%+200.5%1.077%Search for SEC Filing on Google Icon
2/7/2022Royce & Associates LP106,696$0.17M0.0%-52.7%0.373%Search for SEC Filing on Google Icon
11/12/2021Johnson & Johnson2,133,402$6.53M0.6%N/A7.568%Search for SEC Filing on Google Icon
10/26/2021Taylor Wealth Management Partners40,098$91K0.0%-44.3%0.142%Search for SEC Filing on Google Icon
8/17/2021Millennium Management LLC427,702$2.34M0.0%-5.9%1.758%Search for SEC Filing on Google Icon
8/17/2021Bridgeway Capital Management LLC104,000$0.57M0.0%-15.4%0.427%Search for SEC Filing on Google Icon
5/18/2021Millennium Management LLC454,377$3.24M0.0%-1.2%1.954%Search for SEC Filing on Google Icon
5/18/2021Jane Street Group LLC25,365$0.18M0.0%N/A0.109%Search for SEC Filing on Google Icon
5/13/2021Renaissance Technologies LLC36,200$0.26M0.0%N/A0.156%Search for SEC Filing on Google Icon
5/10/2021Royce & Associates LP359,000$2.56M0.0%N/A1.544%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
BiomX logo
BiomX Inc., a clinical-stage biopharmaceutical company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria associated with chronic disease. It is developing BX211, a phage therapy, which is in phase 2 clinical study for the treatment of diabetic foot osteomyelitis. The company's product pipeline also includes BX004, a phage therapy for cystic fibrosis patients with chronic pulmonary infections caused by Pseudomonas aeruginosa that is in Phase 1b/2a clinical trials. BiomX Inc. was founded in 2015 and is headquartered in Ness Ziona, Israel.
Read More on BiomX

Today's Range

Now: $0.87
Low: $0.87
High: $0.91

50 Day Range

MA: $1.07
Low: $0.14
High: $1.72

52 Week Range

Now: $0.87

Volume

34,316 shs

Average Volume

68,601 shs

Market Capitalization

$60.84 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.29

Who are the company insiders with the largest holdings of BiomX?

BiomX's top insider shareholders include:
  1. Israel Biofund Gp Limi Orbimed (Major Shareholder)
  2. Chidozie Ugwumba (Major Shareholder)
  3. Assaf Oron (Insider)
Learn More about top insider investors at BiomX.
Urgent: This election is rigged
From Porter & Company   |   Ad
If you missed it, my emergency election broadcast is now available - but will be removed soon
Click here to watch it now.